Atlas FDA

OPX

3 FDA 510(k) clearances · Product code

FDA profile

Official device name
Immunoglobulin A Kappa Heavy & Light Chain Combined
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5510
Medical specialty
Immunology
Flags
Third-party review eligible
FDA definition
Intended for the in-vitro quantification of iga kappa concentration in human serum. The result is to be used with previously diagnosed iga multiple myeloma, in conjunction with other clinical and laboratory findings. For previously diagnosed iga multiple myeloma patients.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
Optilite Hevylite IgA Kappa Kit, Optilite Hevylite IgA Lambda Kit (K160819)The Binding Site Group , Ltd.2016-06-16
Hevylite Human IgA Kappa Kit for use on SPAPLUS, Hevylite Human IgA Lambda Kit for use on SPAPLUS (K151759)The Binding Site Group , Ltd.2015-11-06
HEVYLITE HUMAN IGA KAPPA KIT FOR USE ON SIEMENS BNII, HEVYLITE HUMAN IGA LAMBDA KIT FOR USE ON SIEMENS BNII (K140105)The Binding Site2014-03-18

Track OPX automatically

Every clearance here is in the API, with alerts when new ones post.